A. Bulgarelli

发表

Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits

B. Caramelli, R. Maranhão, A. Bulgarelli, 2012, Journal of cardiovascular pharmacology.

Identification of 9 novel transcripts and two RGSL genes within the hereditary prostate cancer region (HPC1) at 1q25.

C. V. Jongeneel, Brian J. Stevenson, A. Camargo, 2003, Gene.

Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles

R. Maranhão, F. Freitas, A. Bulgarelli, 2016, Cardiovascular Drugs and Therapy.

Anti-Atherogenic Effects of Methotrexate Carried by a Lipid Nanoemulsion That Binds to LDL Receptors in Cholesterol-fed Rabbits

R. Maranhão, A. A. Dias, A. Bulgarelli, 2013, Cardiovascular Drugs and Therapy.

Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis

E. Bonfá, E. Tavares, R. Maranhão, 2013, International journal of nanomedicine.

Role of fibrinogen in atherosclerosis: therapeutic effects of bezafibrate in short-term treatment

G. Pagano, A. Bulgarelli, P. Nuccio, 1987 .

Epstein-Barr Viral Load in Post Renal Transplant Lymphoproliferative Disease: Elevated EBV DNA Levels at Diagnosis and Clearence after Rituximab Therapy.

M. Franco, O. Caballero, J. Pestana, 2004 .

Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients.

M. Cassader, G. Pagano, A. Bulgarelli, 1988, Atherosclerosis.

Epstein – Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case – control study in a renal transplant cohort

M. Franco, O. Caballero, J. Pestana, 2005, Leukemia & lymphoma.